Nanomedicine News

RSS

Researchers Find Unique Pattern in Leukemia Cells Using Microarray Technology

Nearly half of patients with the most common form of adult leukemia are said to have normal chromosomes but appear instead to have a distinct pattern of genetic abnormalities that could better define their prognosis and treatment, researchers report.

31 Mar 2014

Celator Begins Clinical Study of CPX-351 in High Risk MDS and AML Patients

Celator Pharmaceuticals, Inc., a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that patients have been enrolled in an investigator-initiated clinical study evaluating CPX-351 (cytarabine:daunorubicin) Liposome Injection as a treatment for patients with higher risk myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML), who are refractory to or in relapse after hypomethylating agent (HMA) therapy.

28 Mar 2014

TSRI Scientists Develop Method of Modifying Organic Molecules for Improving Medical Care

Advancements targeted to improving medical care continue to provide tools that could advance development of high throughput atomically precise manufacturing. In the latest example, chemists have developed a method to add a functional group to a specific carbon atom several atoms away from a given atom.

28 Mar 2014

Australia and the Philippines Award Fundamental Patents to NanoViricides

NanoViricides, Inc. (the "Company"), announced today that a fundamental PCT patent application, on which the nanoviricides® technology is based, has resulted in additional issued patents in Australia and the Philippines.

From NanoViricides, Inc 25 Mar 2014

Comprehensive Report Analyzes Worldwide Markets for Nanotechnology in Drug Delivery

Research and Markets has announced the addition of the "Nanotechnology in Drug Delivery - Global Strategic Business Report" report to their offering.

From Research and Markets 25 Mar 2014

FDA Approves IDE Trial for Coronary Stent System with Polyzene-F Nano-Coating Technology

CeloNova BioSciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted approval to start an investigative device exemption (IDE) trial for its novel coronary stent system – the Cobra PzF™ coronary stent system. Coronary stents are thin wire mesh devices used in minimally invasive heart surgery to prop open clogged blood vessels of the heart.

20 Mar 2014

Nano-Flares May Help Create New Type of Breast Cancer Diagnostic

When cancer spreads from one part of the body to another, it becomes even more deadly. It moves with stealth and can go undetected for months or years. But a new technology that uses “nano-flares” has the potential to catch these lurking, mobilized tumor cells early on. Today, scientists presented the latest advances in nano-flare technology as it applies to the detection of metastatic breast cancer cells.

20 Mar 2014